Skip to main content
. Author manuscript; available in PMC: 2018 Jun 1.
Published in final edited form as: J Cardiol. 2016 Nov 23;69(6):868–876. doi: 10.1016/j.jjcc.2016.08.010

Figure 3.

Figure 3

Adjusted hazard ratios (95% confidence intervals) of outcomes in switchers to dabigatran to warfarin users across selected subgroups, MarketScan Databases, 2009 to 2012.

MI, myocardial infarction; GI, gastrointestinal.